Jim Cramer wrote in a column Wednesday that there is no shortage of bright spots in the stock market, especially in the science and innovation space. Cramer singled out vaccine maker Moderna (MRNA) as one such bright spot. Shares of Moderna have rallied significantly over the past 12 months. Is there more room to rally? Let's check out the charts and indicators.
More from Investing
We must figure out what really happened on the move up, because it had as much to do with real-world prices of assets as it did with the end of COVID doom.
The stocks that hungry traders favor the most performed poorly and speculative liquidity dried up.
This market is either going to test your patience or your fortitude.